Harvard Bioscience (NASDAQ:HBIO – Get Free Report) released its quarterly earnings results on Tuesday. The medical instruments supplier reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.62) by $0.29, FiscalAI reports. The company had revenue of $20.76 million for the quarter, compared to analysts’ expectations of $21.20 million. Harvard Bioscience [...]
Harvard Bioscience (NASDAQ:HBIO) Posts Quarterly Earnings Results, Beats Expectations By $0.29 EPS
